Atlas Trials

A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension

Clinical trial NCT00150267 · COMPLETED

Trial details

NCT number
NCT00150267
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Glaucoma, Open-AngleOcular Hypertension
Start date
2002-02-01
Enrollment
976

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.